{"id":"https://openalex.org/W2019628007","doi":"https://doi.org/10.1111/j.1476-5381.1993.tb13610.x","title":"Comparison between carvedilol and captopril in rats with partial ablation\u2010induced chronic renal failure","display_name":"Comparison between carvedilol and captopril in rats with partial ablation\u2010induced chronic renal failure","publication_year":1993,"publication_date":"1993-06-01","ids":{"openalex":"https://openalex.org/W2019628007","doi":"https://doi.org/10.1111/j.1476-5381.1993.tb13610.x","mag":"2019628007","pmid":"https://pubmed.ncbi.nlm.nih.gov/8102931","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/2175699"},"language":"en","primary_location":{"id":"doi:10.1111/j.1476-5381.1993.tb13610.x","doi":"https://doi.org/10.1111/j.1476-5381.1993.tb13610.x","is_oa":true,"landing_page_url":"https://doi.org/10.1111/j.1476-5381.1993.tb13610.x","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/j.1476-5381.1993.tb13610.x","source":{"id":"https://openalex.org/S55107261","display_name":"British Journal of Pharmacology","issn_l":"0007-1188","issn":["0007-1188","1476-5381"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British Journal of Pharmacology","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/j.1476-5381.1993.tb13610.x","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5038388236","display_name":"David P. Brooks","orcid":"https://orcid.org/0009-0000-6847-3291","observed_orcids":["https://orcid.org/0009-0000-6847-3291"]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"David P. Brooks","raw_affiliation_strings":["Department of Renal Pharmacology, SmithKline Beecham Pharmaceuticals, King of Prussia, PA 19406-0939"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Renal Pharmacology, SmithKline Beecham Pharmaceuticals, King of Prussia, PA 19406-0939","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5054275002","display_name":"Brian G. Short","orcid":"https://orcid.org/0000-0002-5616-8422","observed_orcids":["https://orcid.org/0000-0002-5616-8422"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Brian G. Short","raw_affiliation_strings":["Departments of Renal Pharmacology, Toxicology-U.S. and Drug Metabolism, and Division of Pharmacological Sciences, SmithKline Beecham Pharmaceuticals, King of Prussia, PA 19406-0939, U.S.A"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Departments of Renal Pharmacology, Toxicology-U.S. and Drug Metabolism, and Division of Pharmacological Sciences, SmithKline Beecham Pharmaceuticals, King of Prussia, PA 19406-0939, U.S.A","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110181270","display_name":"Matthew J. Cyronak","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Matthew J. Cyronak","raw_affiliation_strings":["Departments of Renal Pharmacology, Toxicology-U.S. and Drug Metabolism, and Division of Pharmacological Sciences, SmithKline Beecham Pharmaceuticals, King of Prussia, PA 19406-0939, U.S.A"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Departments of Renal Pharmacology, Toxicology-U.S. and Drug Metabolism, and Division of Pharmacological Sciences, SmithKline Beecham Pharmaceuticals, King of Prussia, PA 19406-0939, U.S.A","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103581401","display_name":"Lisa C. Contino","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Lisa C. Contino","raw_affiliation_strings":["Departments of Renal Pharmacology, Toxicology-U.S. and Drug Metabolism, and Division of Pharmacological Sciences, SmithKline Beecham Pharmaceuticals, King of Prussia, PA 19406-0939, U.S.A"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Departments of Renal Pharmacology, Toxicology-U.S. and Drug Metabolism, and Division of Pharmacological Sciences, SmithKline Beecham Pharmaceuticals, King of Prussia, PA 19406-0939, U.S.A","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5017698769","display_name":"Martin DiCristo","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Martin DiCristo","raw_affiliation_strings":["Departments of Renal Pharmacology, Toxicology-U.S. and Drug Metabolism, and Division of Pharmacological Sciences, SmithKline Beecham Pharmaceuticals, King of Prussia, PA 19406-0939, U.S.A"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Departments of Renal Pharmacology, Toxicology-U.S. and Drug Metabolism, and Division of Pharmacological Sciences, SmithKline Beecham Pharmaceuticals, King of Prussia, PA 19406-0939, U.S.A","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100328549","display_name":"Yixin Wang","orcid":"https://orcid.org/0000-0003-4324-2408","observed_orcids":["https://orcid.org/0000-0003-4324-2408"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Yi\u2010Xin Wang","raw_affiliation_strings":["Departments of Renal Pharmacology, Toxicology-U.S. and Drug Metabolism, and Division of Pharmacological Sciences, SmithKline Beecham Pharmaceuticals, King of Prussia, PA 19406-0939, U.S.A"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Departments of Renal Pharmacology, Toxicology-U.S. and Drug Metabolism, and Division of Pharmacological Sciences, SmithKline Beecham Pharmaceuticals, King of Prussia, PA 19406-0939, U.S.A","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5112288569","display_name":"Robert R. Ruffolo Jr.","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Robert R. Ruffolo","raw_affiliation_strings":["Departments of Renal Pharmacology, Toxicology-U.S. and Drug Metabolism, and Division of Pharmacological Sciences, SmithKline Beecham Pharmaceuticals, King of Prussia, PA 19406-0939, U.S.A"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Departments of Renal Pharmacology, Toxicology-U.S. and Drug Metabolism, and Division of Pharmacological Sciences, SmithKline Beecham Pharmaceuticals, King of Prussia, PA 19406-0939, U.S.A","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":["https://openalex.org/A5038388236"],"corresponding_institution_ids":[],"apc_list":{"value":4780,"currency":"USD","value_usd":4780},"apc_paid":null,"fwci":0.3701,"has_fulltext":true,"cited_by_count":37,"citation_normalized_percentile":{"value":0.54983203,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":95},"biblio":{"volume":"109","issue":"2","first_page":"581","last_page":"586"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10408","display_name":"Chronic Kidney Disease and Diabetes","score":0.5648999810218811,"subfield":{"id":"https://openalex.org/subfields/2727","display_name":"Nephrology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10408","display_name":"Chronic Kidney Disease and Diabetes","score":0.5648999810218811,"subfield":{"id":"https://openalex.org/subfields/2727","display_name":"Nephrology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11001","display_name":"Renin-Angiotensin System Studies","score":0.3855000138282776,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10684","display_name":"Acute Kidney Injury Research","score":0.013100000098347664,"subfield":{"id":"https://openalex.org/subfields/2727","display_name":"Nephrology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/carvedilol","display_name":"carvedilol","score":0.9980000257492065},{"id":"https://openalex.org/keywords/captopril","display_name":"captopril","score":1.0},{"id":"https://openalex.org/keywords/chronic-kidney-disease","display_name":"chronic kidney disease","score":0.9660000205039978},{"id":"https://openalex.org/keywords/beta-blockers","display_name":"beta-blockers","score":0.8830000162124634},{"id":"https://openalex.org/keywords/ace-inhibitors","display_name":"ACE inhibitors","score":0.906000018119812},{"id":"https://openalex.org/keywords/proteinuria","display_name":"proteinuria","score":0.6539999842643738},{"id":"https://openalex.org/keywords/glomerular-filtration-rate","display_name":"glomerular filtration rate","score":0.9610000252723694},{"id":"https://openalex.org/keywords/plasma-renin-activity","display_name":"plasma renin activity","score":0.9649999737739563},{"id":"https://openalex.org/keywords/glomerular-hypertrophy","display_name":"glomerular hypertrophy","score":0.8930000066757202},{"id":"https://openalex.org/keywords/glomerulosclerosis","display_name":"glomerulosclerosis","score":0.9990000128746033},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.628000020980835},{"id":"https://openalex.org/keywords/renal-protection","display_name":"renal protection","score":0.39899998903274536},{"id":"https://openalex.org/keywords/rats","display_name":"rats","score":0.3479999899864197},{"id":"https://openalex.org/keywords/angiotensin-ii-receptor-blockade","display_name":"angiotensin II receptor blockade","score":0.5099999904632568},{"id":"https://openalex.org/keywords/angiotensin-converting-enzyme-inhibition","display_name":"angiotensin-converting enzyme inhibition","score":0.3190000057220459}],"concepts":[{"id":"https://openalex.org/C2779479957","wikidata":"https://www.wikidata.org/wiki/Q421119","display_name":"Captopril","level":3,"score":0.9099414348602295},{"id":"https://openalex.org/C2780591200","wikidata":"https://www.wikidata.org/wiki/Q412534","display_name":"Carvedilol","level":3,"score":0.8460398316383362},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5974810719490051},{"id":"https://openalex.org/C164705383","wikidata":"https://www.wikidata.org/wiki/Q10379","display_name":"Cardiology","level":1,"score":0.48139524459838867},{"id":"https://openalex.org/C2778902805","wikidata":"https://www.wikidata.org/wiki/Q322177","display_name":"Ablation","level":2,"score":0.4755237400531769},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.43526753783226013},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.4223794639110565},{"id":"https://openalex.org/C2778198053","wikidata":"https://www.wikidata.org/wiki/Q181754","display_name":"Heart failure","level":2,"score":0.3801129162311554},{"id":"https://openalex.org/C84393581","wikidata":"https://www.wikidata.org/wiki/Q82642","display_name":"Blood pressure","level":2,"score":0.12701192498207092}],"mesh":[{"descriptor_ui":"D000077261","descriptor_name":"Carvedilol","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000319","descriptor_name":"Adrenergic beta-Antagonists","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D000319","descriptor_name":"Adrenergic beta-Antagonists","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001794","descriptor_name":"Blood Pressure","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D001806","descriptor_name":"Blood Urea Nitrogen","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002216","descriptor_name":"Captopril","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D002216","descriptor_name":"Captopril","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D002227","descriptor_name":"Carbazoles","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D002227","descriptor_name":"Carbazoles","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D003404","descriptor_name":"Creatinine","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D005923","descriptor_name":"Glomerulosclerosis, Focal Segmental","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D005923","descriptor_name":"Glomerulosclerosis, Focal Segmental","qualifier_ui":"Q000209","qualifier_name":"etiology","is_major_topic":false},{"descriptor_ui":"D006339","descriptor_name":"Heart Rate","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D006973","descriptor_name":"Hypertension","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D006973","descriptor_name":"Hypertension","qualifier_ui":"Q000209","qualifier_name":"etiology","is_major_topic":false},{"descriptor_ui":"D007668","descriptor_name":"Kidney","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D007668","descriptor_name":"Kidney","qualifier_ui":"Q000502","qualifier_name":"physiology","is_major_topic":true},{"descriptor_ui":"D007676","descriptor_name":"Kidney Failure, Chronic","qualifier_ui":"Q000150","qualifier_name":"complications","is_major_topic":false},{"descriptor_ui":"D007676","descriptor_name":"Kidney Failure, Chronic","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D007676","descriptor_name":"Kidney Failure, Chronic","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011412","descriptor_name":"Propanolamines","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D011412","descriptor_name":"Propanolamines","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D011507","descriptor_name":"Proteinuria","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D011507","descriptor_name":"Proteinuria","qualifier_ui":"Q000209","qualifier_name":"etiology","is_major_topic":false},{"descriptor_ui":"D017207","descriptor_name":"Rats, Sprague-Dawley","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D051381","descriptor_name":"Rats","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":3,"locations":[{"id":"doi:10.1111/j.1476-5381.1993.tb13610.x","doi":"https://doi.org/10.1111/j.1476-5381.1993.tb13610.x","is_oa":true,"landing_page_url":"https://doi.org/10.1111/j.1476-5381.1993.tb13610.x","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/j.1476-5381.1993.tb13610.x","source":{"id":"https://openalex.org/S55107261","display_name":"British Journal of Pharmacology","issn_l":"0007-1188","issn":["0007-1188","1476-5381"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British Journal of Pharmacology","raw_type":"journal-article"},{"id":"pmid:8102931","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/8102931","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British journal of pharmacology","raw_type":"Comparative Study"},{"id":"pmh:oai:pubmedcentral.nih.gov:2175699","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC2175699/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Br J Pharmacol","raw_type":"Text"}],"best_oa_location":{"id":"doi:10.1111/j.1476-5381.1993.tb13610.x","doi":"https://doi.org/10.1111/j.1476-5381.1993.tb13610.x","is_oa":true,"landing_page_url":"https://doi.org/10.1111/j.1476-5381.1993.tb13610.x","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/j.1476-5381.1993.tb13610.x","source":{"id":"https://openalex.org/S55107261","display_name":"British Journal of Pharmacology","issn_l":"0007-1188","issn":["0007-1188","1476-5381"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British Journal of Pharmacology","raw_type":"journal-article"},"sustainable_development_goals":[{"score":0.9940000176429749,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2019628007.pdf","grobid_xml":"https://content.openalex.org/works/W2019628007.grobid-xml"},"referenced_works_count":27,"referenced_works":["https://openalex.org/W1269748144","https://openalex.org/W1590233037","https://openalex.org/W1883697851","https://openalex.org/W1964676918","https://openalex.org/W1971898511","https://openalex.org/W1992753219","https://openalex.org/W1997272601","https://openalex.org/W1997708403","https://openalex.org/W2009598063","https://openalex.org/W2012208587","https://openalex.org/W2030971346","https://openalex.org/W2050188434","https://openalex.org/W2063928700","https://openalex.org/W2066799748","https://openalex.org/W2071307509","https://openalex.org/W2072990621","https://openalex.org/W2077873446","https://openalex.org/W2082096135","https://openalex.org/W2087982426","https://openalex.org/W2146235460","https://openalex.org/W2231812784","https://openalex.org/W2307265799","https://openalex.org/W2317676711","https://openalex.org/W2408893981","https://openalex.org/W2415671322","https://openalex.org/W2468419667","https://openalex.org/W2996479446"],"related_works":["https://openalex.org/W2075523436","https://openalex.org/W2411473669","https://openalex.org/W7046668337","https://openalex.org/W2071307509","https://openalex.org/W2121067768","https://openalex.org/W2374466186","https://openalex.org/W2084992670","https://openalex.org/W2054574878","https://openalex.org/W2440019611","https://openalex.org/W82209922"],"abstract_inverted_index":{"1.":[0],"The":[1,276],"effect":[2],"of":[3,35,54,75,92,202,288],"the":[4,19,29,33,50,55,93,203,266,286],"novel":[5],"beta-adrenoceptor":[6],"antagonist":[7],"and":[8,21,62,87,106,211,236],"vasodilator,":[9],"carvedilol":[10,217,225,281],"(SK&F":[11],"105517,":[12],"approximately":[13],"70":[14],"mg":[15,25,60,67,81,98,104,112,118,138,144],"kg-1":[16,26],"daily":[17,27],"in":[18,28,39,131,165,177,213,284,292],"food),":[20],"captopril":[22,219],"(approximately":[23],"38":[24],"drinking":[30],"fluid)":[31],"on":[32,238],"progression":[34,287],"chronic":[36,289],"renal":[37,48,290],"failure":[38,291],"rats":[40,77,167,267],"was":[41,70,151,159,234],"studied.":[42],"2.":[43],"Six":[44],"weeks":[45],"following":[46],"partial":[47],"ablation,":[49],"urinary":[51],"protein":[52],"excretion":[53],"carvediol-":[56],"(60":[57],"+/-":[58,65,79,96,102,110,116,136,142,169,181,192,242,253],"21":[59],"day-1)":[61,68],"captopril-treated":[63,107,166],"(35":[64],"9":[66],"animals":[69,120,133,190,215],"less":[71],"than":[72,128,176],"50%":[73],"that":[74,129,147,265,280],"control":[76,132,189],"(133":[78],"27":[80],"d-1).":[82],"3.":[83],"Serum":[84,224],"creatinine":[85],"(Scr)":[86],"urea":[88],"nitrogen":[89],"(SUN)":[90],"concentrations":[91],"carvedilol-(Scr,":[94],"0.63":[95],"0.09":[97],"dl-1;":[99,113,139],"SUN,":[100,114,140],"11.3":[101],"1.2":[103],"dl-1)":[105,119],"(Scr,":[108,134],"0.82":[109],"0.05":[111],"14.1":[115],"1.5":[117],"were":[121],"also":[122],"significantly":[123,160,207],"(P":[124,161],"<":[125,162],"0.05)":[126,163],"lower":[127],"observed":[130],"1.4":[135,182],"0.3":[137],"19.2":[141],"3.9":[143],"dl-1),":[145],"indicating":[146],"glomerular":[148,209],"filtration":[149],"rate":[150],"improved":[152],"by":[153],"both":[154],"drugs.":[155],"Plasma":[156],"renin":[157],"activity":[158],"higher":[164],"(24.7":[168],"4.6":[170],"ng":[171,183,194,244,255],"angiotensin":[172,184,195],"I":[173,185,196],"ml-1":[174,186,197,245,256],"h-1)":[175,187],"either":[178],"carvedilol-treated":[179],"(7.9":[180],"or":[188,218],"(7.4":[191],"1.0":[193],"h-1).":[198],"4.":[199],"Histological":[200],"examination":[201],"kidneys":[204],"demonstrated":[205],"a":[206],"reduced":[208],"hypertrophy":[210],"glomerulosclerosis":[212],"those":[214],"receiving":[216],"compared":[220],"to":[221,251,274],"controls.":[222],"5.":[223],"concentration":[226],"measured":[227],"every":[228],"6":[229],"h":[230,233,248,259,271],"for":[231],"24":[232,270],"variable":[235],"ranged":[237],"average":[239],"from":[240],"57":[241],"13":[243],"at":[246,257],"16":[247],"00":[249,260],"min":[250],"121":[252],"31":[254],"03":[258],"min.":[261],"These":[262],"data":[263],"indicate":[264],"probably":[268],"had":[269],"systemic":[272],"exposure":[273],"carvedilol.6.":[275],"present":[277],"study":[278],"indicates":[279],"is":[282],"effective":[283],"attenuating":[285],"rats.":[293]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2020,"cited_by_count":1},{"year":2016,"cited_by_count":1},{"year":2013,"cited_by_count":2},{"year":2012,"cited_by_count":1}],"updated_date":"2026-11-10T11:39:43.021295","created_date":"2016-06-24T00:00:00"}